Bioengineering professors Kevin Healy and Luke Lee and collaborators are one of only eleven top university teams nationwide to receive a Phase Two Tissue Chip Award from the NIH National Center for Advancing Translational Sciences (NCATS).
Berkeley BioE ranked #9 program in U.S.
Not only is Berkeley the #1 public university in the nation, Berkeley Bioengineering has been ranked the #9 bioengineering undergraduate program in the US, by U.S. News & World Report. This is one step higher than last year’s ranking – #1, here we come!
New book from Sanjay Kumar
BioE professor Sanjay Kumar has edited a new book with Professor Adam Engler, of UC San Diego. Titled Mechanotransduction, the book is Volume 126 in the Progress in Molecular Biology and Translational Science series.
Biochip research in the Daily Cal
Pioneering research by Professors Kevin Healy and Luke Lee, aimed at recreating human heart and liver tissues on “biochips”, was featured in the Daily Cal.
BioE receives computational biology curriculum enrichment grant
UC Berkeley has awarded a 2014-2015 Presidential Chair Fellows Curriculum Enrichment Grant to the Department of Bioengineering for revision of the undergraduate computational biology concentration.
Healy Lab in Wired News
New research on “organs-on-a-chip” in Professor Kevin Healy’s lab is featured on Wired.com this week!
BioE research on Danish TV
Danish TV program, “Tech and City” filmed an episode at UC Berkeley featuring technology from two bioengineering faculty laboratories. They showcased Professor Seung-Wuk Lee’s virus-electric energy work, and the CellScope project from Professor Dan Fletcher’s lab, explained by PhD alum and lecturer Frankie Myers.
First shipment of malaria drug heads to Africa
The first 1.7 million treatments of semi-synthetic artemisinin, engineered by Professor Jay Keasling’s lab using synthetic biology, has been shipped to malaria-endemic countries in Africa.
Keasling boosts bioengineering on Capitol Hill
UC Berkeley professor and synthetic biology pioneer Jay Keasling called for ‘national initiative’ to boost bioengineering, stressing the need for a federal strategy to ensure continued U.S. leadership in a field he said can yield significant medical benefits for people throughout the world, “and even save lives.”